Clinical Trials - June 4, 2019
Rapid progress of Sigrid Therapeutics trial
The company has completed treatment of 25% of patients in the STAR trial of its medical device, SiPore15, and is well on track to finalize results by Q4 of this year. The company also reports that treatment compliance is good and the safety profile continues to look positive. STAR trial STAR aims to demonstrate that […]
In a new job - May 20, 2019
She is the new Chair of the Research-based Pharmaceutical Industry in Sweden
Malin Parkler, CEO of Pfizer Sweden, has been appointed new Chair of the Board of the Research-based Pharmaceutical Industry in Sweden (LIF). Parkler was elected to the Board of LIF in 2014 and she was elected Vice Chair of the Board of LIF in 2018. Since February 2019 she has been the Chair of the […]
Business article - May 20, 2019
Carina Schmidt among top 20 women in leading biotech roles in Europe
Labiotech.eu has chosen to highlight 20 women they think are making an impact in the European biotech industry, and among them is Carina Schmidt, the CEO of Athera Biotechnologies. Like many technological fields, people with leading roles in big biotech companies have been predominantly male. Nowadays, female representation in biotech leadership roles is slowly increasing, and […]
Clinical Trials - May 16, 2019
Disappointing trial results from Modus Therapeutics
The company announces initial results from its Phase II, randomized, double-blind, placebo-controlled study with sevuparin for the management of acute vaso-occlusive crisis (VOC) in patients with sickle cell disease. Data from the study failed to show a meaningful benefit in the total study population, however, the data suggests that sevuparin, at the administered doses, is […]
Uncategorized - May 14, 2019
Bayer’s new office at Karolinska Institutet is inaugurated
The inauguration was celebrated with a half-day event in Aula Medica focusing on science and collaboration. “Both Bayer and Karolinska Institutet welcomes collaboration between academia, healthcare and society – it is necessary to collaborate to meet global challenges – we are all in this together,” said Miriam Holstein, CEO of Bayer Nordics when she started […]
Business Award - May 13, 2019
Sana Alajmovic hits GEN’s 2019 Top 10 Under 40
The international life sciences journal Genetic Engineering News (GEN) has placed Sana Alajmovic, CEO of Sigrid Therapeutics, on its Top 10 Under 40 of 2019, a list of rising stars making their mark in business and academia. The list casts its net internationally to identify emerging leaders among life sciences professionals working in a university, a […]